V
02500
Venus Medtech (Hangzhou)
1.230
-0.020-1.60%Closed16:08 06/30 HKT
OPEN/PREV CLOSE1.200/1.350
TODAY RANGE1.200-1.830
VOL6.96M
MARKET CAP785.00M
52 WEEK RANGE1.060-5.470
AVG VOL (3M)1.15M
% TURNOVER1.58%
TURNOVER11.68M
P/E (TTM)-1.739
% RANGE46.67%
EPS(TTM)-1.024
P/E(FORWARD)171.154
P/B0.402
BVPS4.425
DIVIDEND--
P/S2.311
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP785.00M
SHARES OUTSTANDING441.01M
NEXT EARNINGS08/26-08/31
FREE FLOAT441.01M
LOT SIZE500
EX-DATE--
News
Press Releases
Financial Reports
Profile
PUBT·05/26 07:00
Venus Medtech hosts inaugural Global Partner Summit in Paris
PUBT·05/15 11:37
Venus MedTech says executive director Ma Liqiao resigns
Simply Wall St·05/13 02:35
Analysts Expect Venus Medtech (Hangzhou) Inc. (HKG:2500) To Breakeven Soon
PUBT·04/29 08:41
Venus MedTech Hangzhou publishes 2025 ESG report
Reuters·03/31 12:30
VENUS MEDTECH HANGZHOU FY REVENUE RMB 306.8 MILLION
Simply Wall St·01/22 22:42
Even With A 26% Surge, Cautious Investors Are Not Rewarding Venus Medtech (Hangzhou) Inc.'s (HKG:2500) Performance Completely
Reuters·01/22 04:01
Venus MedTech Sues Edwards Lifesciences for Patent Infringement
Reuters·01/22 04:01
Venus MedTech Faces Patent Infringement Lawsuit Over Heart Valve Technology
Simply Wall St·01/14 22:02
Discover 3 Asian Penny Stocks With Market Caps Larger Than US$100M
Simply Wall St·01/13 23:10
Venus Medtech (Hangzhou) Inc.'s (HKG:2500) market cap rose HK$153m last week; retail investors who hold 59% profited and so did insiders
Reuters·12/23/2025 23:06
Venus MedTech Submits CE MDR Application for Cardiovalve Tricuspid Valve Replacement
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.